The Plastic Surgeon's Verdict: Gender Surgery Is Mutilation, Not Medicine - Dr.Patrick Lappert (#30)
A board-certified reconstructive surgeon with four decades of experience makes the case that gender surgeries constitute cosmetic intervention on a psychiatric condition — something his own profession's ethics prohibit. For British listeners, his testimony lands at a critical moment: the Cass Review concluded that the evidence base for gender medicine was dangerously thin, and NHS England has already pulled back on puberty blockers. Dr Lappert's account of irreversible surgical harms and weak evidence reinforces every concern that led to Tavistock's closure and raises urgent questions about private practice and overseas surgery that British families still pursue.
Dr Patrick Lappert spent more than forty years as a plastic and reconstructive surgeon — trained in general surgery, then sent by the United States Navy for specialist plastic surgery training. He has since testified in legal proceedings concerning gender surgeries and speaks internationally on their evidence base. He is not an outside critic; he is someone who knows the operating theatre from the inside. His central charge should resonate with anyone who followed the Cass Review. Lappert describes gender surgeries as resting on Level 5 evidence — expert opinion alone, the weakest category in evidence-based medicine. Hilary Cass reached a strikingly similar conclusion about the wider gender medicine pathway: that treatments were being presented to families as settled science when the underlying evidence was remarkably thin. The surgical end of that pathway, Lappert argues, has no stronger a foundation — yet it has attracted far less official scrutiny in Britain than the prescribing that precedes it. The episode addresses the physical consequences of these surgeries directly. Lappert describes phalloplasty as producing a result that is essentially non-functional, and details serious complications arising from vaginoplasty involving the surrounding anatomy. His account of mastectomy in young women is particularly striking: he argues the procedure irreversibly damages the nerve pathway involved in the maternal bonding response during breastfeeding. These are not theoretical risks buried in small print; they are outcomes witnessed in practice. For British families considering private surgery — in the UK or abroad — this testimony is directly relevant. At the heart of Lappert's argument is a psychiatric reframing. He contends that the distress driving requests for gender surgery is better understood through body dysmorphic disorder than through identity affirmation. His own profession's ethics codes forbid cosmetic surgery on patients with body dysmorphia, precisely because surgical alteration does not resolve the underlying condition. Performing it anyway, he argues, is not clinical courage — it is a breach of the most basic obligation to do no harm. For British listeners, the moment is significant. The closure of the Tavistock's Gender Identity Development Service and NHS England's pause on puberty blockers for under-eighteens both reflected the evidence concerns Lappert raises. But the surgical question remains largely unresolved in Britain. Private clinics continue to operate, and some families are travelling abroad for procedures the NHS will not provide. Lappert's account of what those procedures actually involve, and what the evidence genuinely shows, bears directly on choices being made right now.
